0001640334-19-000761.txt : 20190507 0001640334-19-000761.hdr.sgml : 20190507 20190507160826 ACCESSION NUMBER: 0001640334-19-000761 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190506 FILED AS OF DATE: 20190507 DATE AS OF CHANGE: 20190507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moss David J CENTRAL INDEX KEY: 0001421930 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38793 FILM NUMBER: 19803160 MAIL ADDRESS: STREET 1: C/O PEGASI ENERGY RESOURCES CORPORATION STREET 2: 218 N. BROADWAY, SUITE 204 CITY: TYLER STATE: TX ZIP: 75702 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inmune Bio, Inc. CENTRAL INDEX KEY: 0001711754 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475205835 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1224 PROSPECT STREET STREET 2: SUITE 150 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 8589643720 MAIL ADDRESS: STREET 1: 1224 PROSPECT STREET STREET 2: SUITE 150 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 form4.xml FORM 4 X0306 4 2019-05-06-06:00 false 0001711754 Inmune Bio, Inc. INMB 0001421930 Moss David J C/O INMUNE BIO INC. 1224 PROSPECT STREET, SUITE 150 LA JOLLA CA 92037 false true true false CFO, Treasurer & Secretary Common Stock 2019-05-06-06:00 4 P false 5000 9 A 1210417 D Includes 5,000 shares of the Issuer's common stock acquired by the Reporting Person in connection with a private placement consummated as of May 6, 2019. /s/ David Moss 2019-05-07-06:00